Top articles 2012
1 = Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Waters, PJ; McKeon, A; Leite, MI; et al.
NEUROLOGY Volume: 78 Issue: 9 Pages: 665-671 Published: FEB 2012
Times Cited: 68 (from Web of Science Core Collection)
2 ˄ Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.
Silberstein, SD; Holland, S; Freitag, F; et al.
NEUROLOGY Volume: 78 Issue: 17 Pages: 1337-1345 Published: APR 2012 Times Cited: 63 (from Web of Science Core Collection)
3 = Total daily physical activity and the risk of AD and cognitive decline in older adults. Buchman, AS; Boyle, PA; Yu, L; et al.
NEUROLOGY Volume: 78 Issue: 17 Pages: 1323-1329 Published: APR 2012 Times Cited: 54 (from Web of Science Core Collection)
4 v Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.
Krauss, GL; Serratosa, JM; Villanueva, V; et al.
NEUROLOGY Volume: 78 Issue: 18 Pages: 1408-1415 Published: MAY 2012 Times Cited: 52 (from Web of Science Core Collection)
4 ˄ Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Coles, AJ; Fox, E; Vladic, A; et al.
NEUROLOGY Volume: 78 Issue: 14 Pages: 1069-1078 Published: APR 2012 Times Cited: 52 (from Web of Science Core Collection)
5 ˄ Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial
Coelho, T; Maia, LF; da Silva, AM; et al.
NEUROLOGY Volume: 79 Issue: 8 Pages: 785-792 Published: AUG 2012 Full Text
Times Cited: 50 (from Web of Science Core Collection)
5 v Patterns of treatment response in newly diagnosed epilepsy.
Brodie, MJ; Barry, SJE; Bamagous, GA; et al.
NEUROLOGY Volume: 78 Issue: 20 Pages: 1548-1554 Published: MAY 2012
Times Cited: 50 (from Web of Science Core Collection)
6 ˄ A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Richard, IH; McDermott, MP; Kurlan, R; et al.
NEUROLOGY Volume: 78 Issue: 16 Pages: 1229-1236 Published: APR 2012
Times Cited: 49 (from Web of Science Core Collection)
Rodrigue, KM; Kennedy, KM; Devous, MD, Sr.; et al.
NEUROLOGY Volume: 78 Issue: 6 Pages: 387-395 Published: FEB 2012
Times Cited: 48 (from Web of Science Core Collection)
8 v Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.
French, Jacqueline A.; Krauss, Gregory L.; Biton, V; et al.
NEUROLOGY Volume: 79 Issue: 6 Pages: 589-596 Published: AUG 2012
Times Cited: 46 (from Web of Science Core Collection)
9 ˄ Reducing in-hospital delay to 20 minutes in stroke thrombolysis.
Meretoja, A; Strbian, D; Mustanoja, S; et al.
NEUROLOGY Volume: 79 Issue: 4 Pages: 306-313 Published: JUL 2012
Times Cited: 43 (from Web of Science Core Collection)
10 v Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort.
Schoonenboom, NSM; Reesink, FE; Verwey, NA; et al.
NEUROLOGY Volume: 78 Issue: 1 Pages: 47-54 Published: JAN 2012
Times Cited: 40 (from Web of Science Core Collection)
Top articles 2011
1 = Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Polman, CH.; Reingold, SC; Banwell, B; et al.
ANNALS OF NEUROLOGY Volume: 69 Issue: 2 Pages: 292-302 Published: FEB 2011 Times Cited: 657 (from Web of Science) A comment to this top article can be found here.
2 = Responsive cortical stimulation for the treatment of medically intractable partial epilepsy
Morrell, MJ; RNS Syst Epilepsy Study Grp
NEUROLOGY Volume: 77 Issue: 13 Pages: 1295-1304 Published: SEP 2011
Times Cited: 106 (from Web of Science)
3 = Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
Zivadinov, R; Marr, K; Cutter, G; et al.
NEUROLOGY Volume: 77 Issue: 2 Pages: 138-144 Published: JUL 2011
Times Cited: 91 (from Web of Science)
4 = Sun exposure and vitamin D are independent risk factors for CNS demyelination Lucas, RM; Ponsonby, A-L; Dear, K; et al.
NEUROLOGY Volume: 76 Issue: 6 Pages: 540-548 Published: FEB 8 2011
Times Cited: 82 (from Web of Science)
5 = Guidelines in practice: treatment of painful diabetic neuropathy Bril,
V.; England, J.; Franklin, G. M.; et al.
NEUROLOGY Volume: 76 Issue: 20 Pages: 1758-1765 Published: MAY 2011
Times Cited: 75 (from Web of Science)
6 ˄ Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
O’Connor, PW; Goodman, A; Kappos, L; et al.
NEUROLOGY Volume: 76 Issue: 22 Pages: 1858-1865 Published: MAY 2011
Times Cited: 72 (from Web of Science)
7 v Screening for tumours in paraneoplastic syndromes: report of an EFNS task force Titulaer, MJ; Soffietti, R; Dalmau, J; et al.
EUROPEAN JOURNAL OF NEUROLOGY Volume: 18 Issue: 1 Pages: 19-E3 Published: JAN 2011
Times Cited: 68 (from Web of Science) A comment to this top article can be found here.
8 v Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
French, JA.; Abou-Khalil, BW; Leroy, RF; et al. RESTORE 1 Study 301 Investigators NEUROLOGY Volume: 76 Issue: 18 Pages: 1555-1563 Published: MAY 2011
Times Cited: 67 (from Web of Science)
8 = Default mode network connectivity in stable vs progressive mild cognitive impairment
Petrella, JR; Sheldon, FC; Prince, SE; et al.
NEUROLOGY.; Volume 76 Issue:6: Pages: 511-7. FEB 8 2011
Times Cited: 67 (from Web of Science)
9 = Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline.
Debette, S; Seshadri, S; Beiser, A; et al.
NEUROLOGY Volume: 77 Issue: 5 Pages: 461-468 Published: AUG 2011
Times Cited: 66 (from Web of Science Core Collection)
10 = Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Cortese, I.; Chaudhry, V.; So, Y. T.; et al.
NEUROLOGY Volume: 76 Issue: 3 Pages: 294-300 Published: JAN 18 2011
Times Cited: 58 (from Web of Science Core Collection)
